Effectiveness of Injectable Platelet Rich Fibrin with Demineralised Freeze Dried Bone Allograft in Class II Furcation Defects: Protocol for a Randomised Clinical Trial

Shirbhate, Unnati Ashokrao and Bajaj, Pavan Suresh (2023) Effectiveness of Injectable Platelet Rich Fibrin with Demineralised Freeze Dried Bone Allograft in Class II Furcation Defects: Protocol for a Randomised Clinical Trial. JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 17 (3). ZK22- ZK26. ISSN 2249782X

[thumbnail of 60868_CE[Ra1]_F(IS)_PF1(DA_KM)_PFA(DA_KM)_PN(KM).pdf] Text
60868_CE[Ra1]_F(IS)_PF1(DA_KM)_PFA(DA_KM)_PN(KM).pdf - Published Version

Download (117kB)

Abstract

Introduction: In cases of substantial furcation involvement, non surgical mechanical debridement results in disease progression. Surgery allows for root debridement, osseous recontouring, odontoblasts, and periodontal regeneration while maintaining periodontal attachment, to stop the disease process. The current study evaluates whether combining injectable-Platelet Rich Fibrin (i-PRF) mixed with Demineralised Freeze-Dried Bone Allograft (DFDBA) for treating class-II furcation diseases is successful.

Need for the study: In comparison to ‘Open Flap Debridement’ (OFD) alone, certain studies have shown that DFDBA results in a considerable and persistent increase in periodontal regeneration. The current study evaluates whether combining i-PRF mixed with DFDBA for treating class-II-furcation diseases is successful or not.

Aim: To compare evaluation of i-PRF with DFDBA compared to DFDBA alone in the treatment of the class-II furcation defects- a randomised controlled clinical trial.

Materials and Methods: The current investigation will be a randomised, double-blinded clinical trial, onb total twenty-four patients of ‘Class-II furcation’ including the buccal/lingual sides of the tooth. By the completion of the first therapy and before the beginning of surgery, the chosen defects will be randomly allotted to group A and group B equally, using a computer-generated randomisation process employing a randomised table. Group A will operate with both i-PRF and DFDBA, whereas group B here will only be given DFDBA. To estimate outcomes, a re-evaluation will be done at six and nine months after starting therapy.

Item Type: Article
Subjects: European Repository > Medical Science
Depositing User: Managing Editor
Date Deposited: 24 Jun 2023 04:51
Last Modified: 12 Oct 2023 05:10
URI: http://go7publish.com/id/eprint/2565

Actions (login required)

View Item
View Item